KalVista Pharmaceuticals, Inc. announced that Rajeev Shah advised the Board of Directors that he would resign as a Class I independent director of the Company and as a member of the Audit and Compensation Committees of the Board, effective immediately. Mr. Shah’s resignation is not the result of any disagreement with the Company on any matter relating to its operations, policies or practices. Following Mr. Shah’s resignation, Albert Cha, M.D., Ph.D. was appointed to the Audit Committee.